TP53 and breast cancer: The median age of TP53 PV carriers at the time of diagnosis of breast cancer appears to be similar in Japan and France: the median ages were 34 years in our study, 32 years in the study by Funato et al. [20], and 33 years in a study of the French LFS working group [10].